JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL

Page 1 <img data-url='document/jcrfffc-l-oeccefffffff.html?page=1' data-page='1' class='cut-thumb lazyload' alt='Page 1: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/1.jpg' width='140' height='200' /> Page 2 <img data-url='document/jcrfffc-l-oeccefffffff.html?page=2' data-page='2' class='cut-thumb lazyload' alt='Page 2: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/2.jpg' width='140' height='200' /> Page 3 <img data-url='document/jcrfffc-l-oeccefffffff.html?page=3' data-page='3' class='cut-thumb lazyload' alt='Page 3: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/3.jpg' width='140' height='200' /> Page 4 <img data-url='document/jcrfffc-l-oeccefffffff.html?page=4' data-page='4' class='cut-thumb lazyload' alt='Page 4: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/4.jpg' width='140' height='200' /> Page 5 <img data-url='document/jcrfffc-l-oeccefffffff.html?page=5' data-page='5' class='cut-thumb lazyload' alt='Page 5: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/5.jpg' width='140' height='200' /> Page 6 <img data-url='document/jcrfffc-l-oeccefffffff.html?page=6' data-page='6' class='cut-thumb lazyload' alt='Page 6: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/6.jpg' width='140' height='200' /> Page 7 <img data-url='document/jcrfffc-l-oeccefffffff.html?page=7' data-page='7' class='cut-thumb lazyload' alt='Page 7: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/7.jpg' width='140' height='200' /> Page 8 <img data-url='document/jcrfffc-l-oeccefffffff.html?page=8' data-page='8' class='cut-thumb lazyload' alt='Page 8: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/8.jpg' width='140' height='200' /> Page 9 <img data-url='document/jcrfffc-l-oeccefffffff.html?page=9' data-page='9' class='cut-thumb lazyload' alt='Page 9: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' loading='lazy' src='data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mNk+P+/HgAFhAJ/wlseKgAAAABJRU5ErkJggg==' data-src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/9.jpg' width='140' height='200' />

JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL

Documents